Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AXP | V |
|---|---|---|
| Price | $303.70 | $365.86 |
| Change today | ▲ 0.58% | ▲ 1.20% |
| Market cap | $205.09B | $684.36B |
| Return, 3 months | -11.1% | +10.3% |
| Return, year to date | -17.2% | +4.9% |
| Return, 1 year | -9.8% | +8.9% |
| P/E (TTM) | 18.4 | 31.1 |
| P/B | 6.0 | 19.5 |
| P/E percentile vs own 5y | 66th | 49th |
| Dividend yield | 1.17% | 0.71% |
| Revenue growth (YoY, latest qtr) | +10.0% | +14.4% |
| Net profit growth (YoY) | +7.8% | +6.8% |
| Gross margin | – | 80.2% |
| Operating margin | – | 65.6% |
| Net margin | 14.9% | 50.3% |
| Return on equity | 34.0% | 61.8% |
| Analyst target vs. price | +25.4% | +17.2% |
| Analyst buy share | 53% | 96% |
| RSI (14) | 28 | 43 |
| 30-day volatility | 20.2% | 18.8% |
| Max drawdown, 1 year | -23.9% | -17.2% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.